[go: up one dir, main page]

PL332957A1 - Method of obtaining nanoparticles of methylidene malonate possibly those containing one or several type of biologically active particles - Google Patents

Method of obtaining nanoparticles of methylidene malonate possibly those containing one or several type of biologically active particles

Info

Publication number
PL332957A1
PL332957A1 PL97332957A PL33295797A PL332957A1 PL 332957 A1 PL332957 A1 PL 332957A1 PL 97332957 A PL97332957 A PL 97332957A PL 33295797 A PL33295797 A PL 33295797A PL 332957 A1 PL332957 A1 PL 332957A1
Authority
PL
Poland
Prior art keywords
biologically active
those containing
active particles
several type
methylidene malonate
Prior art date
Application number
PL97332957A
Other languages
English (en)
Inventor
Nicole Bru-Magniez
Xavier Guillon
Pascal Breton
Patrick Couvreur
Francois Lescure
Claude Roques-Carmes
Gerard Riess
Original Assignee
Virsol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virsol filed Critical Virsol
Publication of PL332957A1 publication Critical patent/PL332957A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
    • C08F22/10—Esters
    • C08F22/12—Esters of phenols or saturated alcohols
    • C08F22/14—Esters having no free carboxylic acid groups
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerisation Methods In General (AREA)
PL97332957A 1996-10-25 1997-10-24 Method of obtaining nanoparticles of methylidene malonate possibly those containing one or several type of biologically active particles PL332957A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613039A FR2755136B1 (fr) 1996-10-25 1996-10-25 Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant
PCT/FR1997/001907 WO1998018455A1 (fr) 1996-10-25 1997-10-24 Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives

Publications (1)

Publication Number Publication Date
PL332957A1 true PL332957A1 (en) 1999-10-25

Family

ID=9497032

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97332957A PL332957A1 (en) 1996-10-25 1997-10-24 Method of obtaining nanoparticles of methylidene malonate possibly those containing one or several type of biologically active particles

Country Status (23)

Country Link
US (2) US6211273B1 (xx)
EP (1) EP0934059B1 (xx)
JP (1) JP2001504530A (xx)
KR (1) KR20000052813A (xx)
CN (1) CN1237903A (xx)
AR (1) AR009127A1 (xx)
AT (1) ATE245171T1 (xx)
AU (1) AU736097B2 (xx)
BR (1) BR9712372A (xx)
CA (1) CA2269783C (xx)
CZ (1) CZ144099A3 (xx)
DE (1) DE69723571T2 (xx)
FR (1) FR2755136B1 (xx)
HU (1) HUP9904359A3 (xx)
IL (1) IL129355A0 (xx)
NO (1) NO991942L (xx)
NZ (1) NZ335094A (xx)
PL (1) PL332957A1 (xx)
RU (1) RU2214421C2 (xx)
SK (1) SK55599A3 (xx)
TW (1) TW503109B (xx)
WO (1) WO1998018455A1 (xx)
ZA (1) ZA979550B (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774096B1 (fr) * 1998-01-29 2000-04-07 Virsol Nouveaux copolymeres tensioactifs a base de methylidene malonate
FR2778100B1 (fr) * 1998-04-29 2001-05-04 Virsol Nouvelles microspheres a base de poly(methylidene malonate), leur procede de preparation et compositions pharmaceutiques les contenant
FR2789314B1 (fr) * 1999-02-09 2001-04-27 Virsol Materiau de suture de plaies a base de methylidene malonate
CN1300270C (zh) * 2000-04-12 2007-02-14 大日本油墨化学工业株式会社 防污涂料组合物和新型树脂
JP4611561B2 (ja) * 2000-04-12 2011-01-12 Ｄｉｃ株式会社 新規なビニル系樹脂およびその製造方法
FR2812551B1 (fr) * 2000-08-07 2003-03-28 Virsol Forme pharmaceutique comprenant un materiau support a base de methylidene malonate et un facteur de regulation cellulaire
WO2002030399A2 (en) * 2000-10-11 2002-04-18 Johns Hopkins University Polymer controlled delivery of a therapeutic agent
KR100457824B1 (ko) * 2001-08-10 2004-11-18 한국화학연구원 용액 열분해법에 의한 나노 크기 2가 금속 산화물 분말의제조
JP3961312B2 (ja) 2002-02-26 2007-08-22 株式会社デンソー 内燃機関の制御装置
US8697120B2 (en) * 2006-05-01 2014-04-15 Johns Hopkins University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
EP2123262A1 (en) 2008-05-20 2009-11-25 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
RU2390016C2 (ru) * 2008-06-16 2010-05-20 Государственное образовательное учреждение высшего профессионального образования Иркутский государственный университет путей сообщения (ИрГУПС (ИрИИТ)) Способ определения рифампицина
US8106234B2 (en) * 2009-05-07 2012-01-31 OptMed, Inc Methylidene malonate process
US8993795B2 (en) 2009-05-07 2015-03-31 Optmed Inc Methylidene malonate process
CN105949358A (zh) 2010-10-20 2016-09-21 瑟拉斯公司 基本不含杂质的亚甲基丙二酸酯的合成
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
US9279022B1 (en) * 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
WO2013059479A2 (en) 2011-10-19 2013-04-25 Bioformix Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
EP2831185B1 (en) 2012-03-30 2019-09-25 Sirrus, Inc. Ink and coating formulations and polymerizable systems for producing the same
US9181365B2 (en) 2012-03-30 2015-11-10 Sirrus, Inc. Methods for activating polymerizable compositions, polymerizable systems, and products formed thereby
CA2869112A1 (en) 2012-03-30 2013-10-03 Bioformix Inc. Composite and laminate articles and polymerizable systems for producing the same
US10047192B2 (en) 2012-06-01 2018-08-14 Sirrus, Inc. Optical material and articles formed therefrom
EP2920231B1 (en) 2012-11-16 2020-05-06 Sirrus, Inc. Plastics bonding systems and methods
CN105164797B (zh) 2012-11-30 2019-04-19 瑟拉斯公司 用于电子应用的复合组合物
WO2014110388A1 (en) 2013-01-11 2014-07-17 Bioformix Inc. Method to obtain methylene malonate via bis(hydroxymethyl) malonate pathway
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
WO2016205605A1 (en) * 2015-06-19 2016-12-22 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
JP7663319B2 (ja) 2017-06-02 2025-04-16 アルケマ フランス 硬化性組成物及びその使用
WO2020123579A1 (en) * 2018-12-11 2020-06-18 Sirrus, Inc. Polymerization of 1,1-dicarbonyl 1-alkenes
US12479947B2 (en) 2019-07-19 2025-11-25 Arkema France Curable compositions useful for obtaining non-sensitizing cured products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329332A (en) * 1978-07-19 1982-05-11 Patrick Couvreur Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them
FR2611705B1 (fr) * 1987-03-05 1989-07-13 Union Pharma Scient Appl Procede de preparation de monesters ou diesters de l'acide endoethano-9, 10 dihydro-9, 10 anthracene bicarboxylique-11, 11, nouveaux monesters ou diesters ainsi prepares et utilisation de ceux-ci pour la preparation de methylenemalonates symetriques ou asymetriques
FR2722411B1 (fr) * 1994-07-18 1996-10-04 Union Pharma Scient Appl Immunonanoparticules revetues d'anticorps monoclonaux anti-beta2 microglobuline et leur utilisation pour la prophylaxie et/ou le traitement de pathologies dues a une infection par le virus hiv

Also Published As

Publication number Publication date
US6211273B1 (en) 2001-04-03
TW503109B (en) 2002-09-21
CA2269783C (en) 2005-01-11
US20010006989A1 (en) 2001-07-05
KR20000052813A (ko) 2000-08-25
AU736097B2 (en) 2001-07-26
CA2269783A1 (en) 1998-05-07
FR2755136A1 (fr) 1998-04-30
ATE245171T1 (de) 2003-08-15
WO1998018455A1 (fr) 1998-05-07
NZ335094A (en) 2001-05-25
HUP9904359A3 (en) 2000-11-28
HUP9904359A2 (hu) 2000-05-28
CN1237903A (zh) 1999-12-08
ZA979550B (en) 1998-05-12
SK55599A3 (en) 2000-03-13
DE69723571T2 (de) 2004-06-03
CZ144099A3 (cs) 1999-09-15
EP0934059A1 (fr) 1999-08-11
EP0934059B1 (fr) 2003-07-16
NO991942L (no) 1999-06-23
BR9712372A (pt) 2000-01-25
AU4950997A (en) 1998-05-22
US6420468B2 (en) 2002-07-16
NO991942D0 (no) 1999-04-23
DE69723571D1 (de) 2003-08-21
AR009127A1 (es) 2000-03-08
IL129355A0 (en) 2000-02-17
FR2755136B1 (fr) 1999-01-22
RU2214421C2 (ru) 2003-10-20
JP2001504530A (ja) 2001-04-03

Similar Documents

Publication Publication Date Title
PL332957A1 (en) Method of obtaining nanoparticles of methylidene malonate possibly those containing one or several type of biologically active particles
HUP0001546A2 (en) Coated particles, methods of making and using
GB2339946B (en) System and method of filtering
EP0739358A4 (en) POROUS AGGREGATE PARTICULATE MATERIALS AND METHOD FOR THE PRODUCTION THEREOF
EP0623687A3 (en) Porous coating implant and method of making the same.
IL128148A0 (en) Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
PL331087A1 (en) Method of obtaining polymer particles
PL331000A1 (en) Method of obtaining polymer particles
AU2725499A (en) Inherently light- and heat-stabilized polyamide and method of making the same
PL336693A1 (en) Novel method of obtaining farmacologically active substances
AP9901599A0 (en) Biologically active substances method for obtaining and compositions containing them
GB9726824D0 (en) Method of manufacturing particles
EP1019925A4 (en) SUBSTRATE FOR MICROELECTRONIC COMPONENT
GB2346823B (en) Reamer and method of using the same
PL341049A1 (en) Agglomerates of particles
PL340927A1 (en) Porous particles of hydroxyapatite as drug carriers
AU3461597A (en) Water-insoluble porous particles of biocompatible substances and process for producing the same
GB9814733D0 (en) Method of reducing or preventing malodour
GB9706070D0 (en) Method of decomposing polychlorodibenzo-p-dioxins and/or polychlorodibenzofurans
GB9804967D0 (en) Masking materials and method of use
GB9814732D0 (en) Method of reducing or preventing malodour
PL330304A1 (en) Granular preparation for repelling aninmals and method of obtaining same
GB9619854D0 (en) Electromagnetic suspension apparatus and method of controlling the same
PL320488A1 (en) Biological laminar dressing and method of making same
ZA982404B (en) Modified molybdenum oxycarbide-based catalysts prepared from oriented molybdenum oxide and method of obtaining the same